Transcranial Doppler ultrasound velocities in a population of unstudied African children with sickle cell anemia
Nicole F. O'Brien,
Peter Moons,
Hunter Johnson,
Taty Tshimanga,
Davin Ambitapio Musungufu,
Robert Tandjeka Ekandji,
Jean Pongo Mbaka,
Lydia Kuseyila Babatila,
Ludovic Mayindombe,
Buba Giresse,
Suzanna Mwanza,
Clement Lupumpaula,
Janet Simanguwa Chilima,
Alice Nanyangwe,
Peter Kabemba,
Lisa Nkole Kafula,
Tusekile Phiri,
Sylvester June,
Montfort Bernard Gushu,
George Chagaluka,
Catherine M. Chunda‐Liyoka
Affiliations
Nicole F. O'Brien
Department of Pediatrics Division of Critical Care Medicine Nationwide Children's Hospital, The Ohio State University Columbus Ohio USA
Peter Moons
Department of Pediatrics and Child Health Kamuzu University of Health Sciences Blantyre Malawi
Hunter Johnson
Department of Pediatrics Division of Critical Care Medicine Nationwide Children's Hospital, The Ohio State University Columbus Ohio USA
Taty Tshimanga
Departement de Pediatrie Cliniques Universitaires de Kinshasa, Hopital Pediatrique de Kalembe Lembe, Universite De Kinshasa Kimwenza Lembe Republique Democratic du Congo
Davin Ambitapio Musungufu
Centre Medicale Evangelique Bunia, Ituri District Bunia Republique Democratic du Congo
Robert Tandjeka Ekandji
Universite des Sciences et des Technologie de Lodja, L'Hopital General de Reference de Lodja, Sankuru District Lodja Republique Democratic du Congo
Jean Pongo Mbaka
Universite des Sciences et des Technologie de Lodja, L'Hopital General de Reference de Lodja, Sankuru District Lodja Republique Democratic du Congo
Lydia Kuseyila Babatila
Departement de Pediatrie Cliniques Universitaires de Kinshasa, Hopital Pediatrique de Kalembe Lembe, Universite De Kinshasa Kimwenza Lembe Republique Democratic du Congo
Ludovic Mayindombe
Departement de Pediatrie Cliniques Universitaires de Kinshasa, Hopital Pediatrique de Kalembe Lembe, Universite De Kinshasa Kimwenza Lembe Republique Democratic du Congo
Buba Giresse
Departement de Pediatrie Cliniques Universitaires de Kinshasa, Hopital Pediatrique de Kalembe Lembe, Universite De Kinshasa Kimwenza Lembe Republique Democratic du Congo
Suzanna Mwanza
Department of Paediatrics Chipata Central Hospital Chipata Zambia
Clement Lupumpaula
Chipata Central Hospital Chipata Zambia
Janet Simanguwa Chilima
Chipata Central Hospital Chipata Zambia
Alice Nanyangwe
University Teaching Hospitals—Children's Hospital Lusaka Zambia
Peter Kabemba
University Teaching Hospitals—Children's Hospital Lusaka Zambia
Lisa Nkole Kafula
University Teaching Hospitals—Children's Hospital Lusaka Zambia
Tusekile Phiri
Queen Elizabeth Central Hospital, The Blantyre Malaria Project, Chichiri Blantyre Malawi
Sylvester June
Queen Elizabeth Central Hospital, The Blantyre Malaria Project, Chichiri Blantyre Malawi
Montfort Bernard Gushu
Queen Elizabeth Central Hospital, The Blantyre Malaria Project, Chichiri Blantyre Malawi
George Chagaluka
Department of Pediatrics and Child Health Kamuzu University of Health Sciences Blantyre Malawi
Catherine M. Chunda‐Liyoka
University Teaching Hospitals—Children's Hospital Lusaka Zambia
Abstract The greatest burden of sickle cell anemia (SCA) globally occurs in sub‐Saharan Africa, where significant morbidity and mortality occur secondary to SCA‐induced vasculopathy and stroke. Transcranial Doppler ultrasound (TCD) can grade the severity of vasculopathy, with disease modifying therapy resulting in stroke reduction in high‐risk children. However, TCD utilization for vasculopathy detection in African children with SCA remains understudied. The objective was to perform a prospective, observational study of TCD findings in a cohort of children with SCA from the Democratic Republic of the Congo, Zambia, and Malawi. A total of 770 children aged 2–17 years without prior stroke underwent screening TCD. A study was scored as low risk when the time‐averaged maximum of the mean (TAMMX) in the middle cerebral artery or terminal internal carotid artery was 50 cm/s, conditional risk when 170–200 cm/s, and high risk when >200 cm/s. Low‐risk studies were identified in 604 children (78%), conditional risk in 129 children (17%), and high risk in three children (0.4%). Additionally, 34 (4%) were scored as having an unknown risk study (TAMMX <50 cm/s). Over the course of 15 months of follow‐up, 17 children (2.2%) developed new neurologic symptoms (six with low‐risk studies, seven with conditional risk, and four with unknown risk). African children with SCA in this cohort had a low rate of high‐risk TCD screening results, even in those who developed new neurologic symptoms. Stroke in this population may be multifactorial with vasculopathy representing only one determinant. The development of a sensitive stroke prediction bundle incorporating relevant elements may help to guide preventative therapies in high‐risk children.